Invention Application
- Patent Title: NUCLEOTIDES FOR THE TREATMENT OF LIVER CANCER
- Patent Title (中): 用于治疗肝癌的核心
-
Application No.: US15039176Application Date: 2014-11-25
-
Publication No.: US20170029456A1Publication Date: 2017-02-02
- Inventor: Cyril B. Dousson , David Dukhan , Christophe Claude Parsy
- Applicant: IDENIX PHARMACEUTICALS LLC
- Applicant Address: US MA Cambridge
- Assignee: IDENIX PHARMACEUTICALS LLC
- Current Assignee: IDENIX PHARMACEUTICALS LLC
- Current Assignee Address: US MA Cambridge
- International Application: PCT/US2014/067485 WO 20141125
- Main IPC: C07H19/207
- IPC: C07H19/207 ; C07H19/10

Abstract:
Provided herein are compounds, compositions and methods for the treatment of liver cancer such as hepatocellular carcinoma, cholangiocarcinoma, or biliary tract cancer. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-cancer agents. In certain embodiments, the compounds are nucleoside analogs of Formula I: (I); or a pharmaceutically acceptable salt thereof, wherein Base, Z1, Z2, Z3, Z4, V, W, X, Ar, R1 and R2 are as described herein.
Public/Granted literature
- US10030044B2 Nucleotides for the treatment of liver cancer Public/Granted day:2018-07-24
Information query
IPC分类: